An MXC BPC-157/TB-500 blend; references address the ingredients individually.
In simple words
Wolverine is an MXC blend listing BPC-157 and TB-500. The selected references concern the ingredients individually, not the combined Wolverine vial, and do not establish effects or synergy of the mixture.
Ingredient studies are shown separately. They do not demonstrate the effects, safety or synergy of the combined vial; exact sequences and unlisted proportions are not assumed.
Evidence on studied compounds does not establish the identity, purity, safety, or regulatory approval of the catalogue vial. No Canadian regulatory status is assessed here.
Research questions about Wolverine
What is Wolverine?
Wolverine is an MXC blend listing BPC-157 and TB-500. The selected references concern the ingredients individually, not the combined Wolverine vial, and do not establish effects or synergy of the mixture.
What types of research are cited for Wolverine?
The Wolverine profile contains the following selected evidence on individual ingredients. This is not a systematic review or a complete inventory of research.
BPC-157 and tendon-cell behaviour (2011): Preclinical — rat tendon cells/explants
Ingredient studies are shown separately. They do not demonstrate the effects, safety or synergy of the combined vial; exact sequences and unlisted proportions are not assumed.
What do the selected Wolverine studies not establish?
BPC-157 and tendon-cell behaviour (2011): Cell/explant findings do not establish tendon healing, efficacy or safety in people.
TB-500 identity and equine detection (2012): This was a detection study, not a healing trial. Full-length thymosin beta-4 research cannot automatically be attributed to TB-500-labelled products.
These studies do not establish the identity, purity, safety or effects of the MXC Wolverine vial. Findings in one formulation, population or experimental model should not be assumed to apply to another.